Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants.
Gaertner, Sébastien
Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants. [electronic resource] - International journal of cardiology 2015 - 141-2 p. digital
Publication Type: Case Reports; Letter
1874-1754
10.1016/j.ijcard.2015.03.234 doi
Aged, 80 and over
Anticoagulants--adverse effects
Atrial Fibrillation--drug therapy
Electrocardiography
Factor Xa Inhibitors--therapeutic use
Female
Humans
Phenindione--adverse effects
Rivaroxaban--therapeutic use
Thrombosis--chemically induced
Vitamin K--antagonists & inhibitors
Prothrombotic risk of vitamin K antagonists during the first days of treatment: One more reason to use new oral anticoagulants. [electronic resource] - International journal of cardiology 2015 - 141-2 p. digital
Publication Type: Case Reports; Letter
1874-1754
10.1016/j.ijcard.2015.03.234 doi
Aged, 80 and over
Anticoagulants--adverse effects
Atrial Fibrillation--drug therapy
Electrocardiography
Factor Xa Inhibitors--therapeutic use
Female
Humans
Phenindione--adverse effects
Rivaroxaban--therapeutic use
Thrombosis--chemically induced
Vitamin K--antagonists & inhibitors